Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Vera Therapeutics Inc (VERA)

Healthcare Biotechnology
32.10 $
-2.9% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Vera Therapeutics Inc (VERA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.5% of the shares are freely tradable; institutional investors hold 110.6%.

Ownership Structure

Institutional ownership
110.6%
Insiders
0.9%
Float
72.5%
Short % of float
18.8%
Shares Outstanding
72Mio.

Largest Shareholders

Institutions

Institutions VERA
Name Stake (%) Shares Change (%) Date
venBio Select Advisor LLC 8.21 5,888,888 +0.0 03/31/2026
BlackRock Inc 7.10 5,088,102 +5.4 03/31/2026
T. Rowe Price Associates, Inc. 6.38 4,574,030 -16.3 03/31/2026
Deep Track Capital, LP 5.73 4,106,067 +45.5 03/31/2026
Deerfield Management Co 5.19 3,722,100 -8.3 03/31/2026
Vanguard Group Inc 4.98 3,570,401 +11.9 12/31/2025
Kynam Capital Management, LP 4.74 3,398,224 -1.0 03/31/2026
State Street Corp 4.69 3,363,638 +25.7 03/31/2026
Sofinnova Ventures 3.90 2,793,987 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.74 2,683,607 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
7. Jul 2026 Fordyce Marshall PRESIDENT AND CEO Sell 2,200 43.59 95,908
7. Jul 2026 Fordyce Marshall PRESIDENT AND CEO Sell 10,500 42.86 450,007
7. Jul 2026 Fordyce Marshall PRESIDENT AND CEO Sell 32,550 42.07 1,369,496
7. Jul 2026 Fordyce Marshall PRESIDENT AND CEO Sell 1,000 40.78 40,776

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?